#TexasLung24 On #physicianburnout : “Never allow life make you forget why you do what you do” —⁦Inky Johnson⁩

⁦Stephen V Liu, MD⁩ ⁦IDEOlogy Health⁩ #lcsm ⁦IASLC⁩

#TexasLung24 Powerful Keynote address by ⁦Inky Johnson⁩ on overcoming adversity, resilience, empowering others and the power of #mindset . #inspired #lcsm

Dr. Jonathan Riess, MD MS with an excellent discussion of the diverse resistance pathways to TKI therapy in EGFRm NSCLC at #TexasLung24 . Resistance-driven and resistance agnostic approaches will hopefully both have a future role.

#TexasLung24 👏👏⁦Narjust Florez, MD, FASCO⁩ ⁦Dana-Farber⁩ - The official queen of #socialmedia & #thoraciconcology walks us thru the process of using social media for good, connecting w patients, networking, clinical trial outreach and finding your voice. ⁦IASLC⁩ #lcsm

🚨Listen to this all-star panel: Dr. Narjust Florez, MD, FASCO, Dr. Christian Rolfo, TerriConneran, Dr.Sandip Patel MD, Dr. Joshua Sabari, MD and Dr. Stephen Schleicher; chaired by Dr. Steven Paulson, as they discuss the 'Tools for Tomorrow's Oncologist'👏👏

Happening NOW ⏲️⏲️ at TLC Conference‼️

Dr. John Heymach dissects the biology of unique EGFR mutations and how this influences therapeutic efficacy at #TexasLung24 . Fascinating to see how the science translates to the clinic!

🧬HRASmut are much less common than KRASmut in solid tumors, but not negligible

💊In fact, there is FDA Breakthrough Therapy designation for a targeted farnesyltransferase inhibitor, tipifarnib, in HRASmut HNSCC

😷What about in other solid tumors?